Literature DB >> 19898430

WHO guidelines presage US biosimilars legislation?

John Hodgson.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19898430     DOI： 10.1038/nbt1109-963a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

Review 1.  Follow-on biologics: data exclusivity and the balance between innovation and competition.

Authors:  Henry Grabowski
Journal:  Nat Rev Drug Discov       Date:  2008-05-12       Impact factor: 84.694

2.  Brand biologics grab 12 years' exclusivity, for now.

Authors:  Randy Osborne
Journal:  Nat Biotechnol       Date:  2009-08       Impact factor: 54.908
  2 in total
  3 in total

1.  Biosimilars: current perspectives and future implications.

Authors:  Monika Misra
Journal:  Indian J Pharmacol       Date:  2012-01       Impact factor: 1.200

Review 2.  Etanercept biosimilars.

Authors:  Valderilio F Azevedo; Nathalia Galli; Alais Kleinfelder; Julia D'Ippolito; Paulo C M Urbano
Journal:  Rheumatol Int       Date:  2014-07-01       Impact factor: 2.631

Review 3.  Biosimilar drugs: Current status.

Authors:  Rajiv Kumar; Jagjit Singh
Journal:  Int J Appl Basic Med Res       Date:  2014-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.